Prior distributions for the intracluster correlation coefficient,based on multiple previous estimates,and their application in cluster randomized trials

Abstract

Numerous estimates for the intracluster correlation coefficient (ICC) are available in research databases and publications. When planning a cluster randomized trial, an anticipated value for the ICC is required; currently, researchers base their choice informally on the magnitude of previous ICC estimates. In this paper, we make use of the wealth of ICC information by formally constructing informative prior distributions, while acknowledging the varying relevance and precision of the estimates available. Typically, for a planned trial in a given clinical setting, multiple relevant ICC estimates are available from each of several completed studies. Our preferred model allows for the imprecision in each ICC estimate around its underlying true value and, separately, allows for the similarity of ICC values from the same study. The relevance of each previous estimate to the planned clinical setting is considered, and estimates corresponding to less relevant outcomes or population types are given less influence. We find that such downweighting can increase the precision of the anticipated ICC. In trial design, the prior distribution constructed allows uncertainty about the ICC to be acknowledged, and we describe how to choose a design that provides adequate power across the range of likely ICC values. Prior information on the ICC can also be incorporated in analysis of the trial data, when taking a Bayesian approach. The methods proposed enable available ICC information to be summarised appropriately by an informative prior distribution, which is of direct practical use in cluster randomized trials.

Get full access to this article

View all access options for this article.

References

1. Donner A , Klar N . Design and analysis of cluster randomization trials in health research. New York: Arnold 2000.

2. Campbell MJ . Cluster randomized trials in general (family) practice research. Statistical Methods in Medical Research 2000; 9: 81–94.

3. Turner RM , Prevost AT , Thompson SG . Allowing for imprecision of the intracluster correlation coefficient in the design of cluster randomized trials. Statistics in Medicine 2004; 23: 1195–1214.

4. Spiegelhalter DJ . Bayesian methods for cluster randomized trials with continuous responses. Statistics in Medicine 2001; 20: 435–452.

5. Turner RM , Omar RZ , Thompson SG . Bayesian methods of analysis for cluster randomized trials with binary outcome data. Statistics in Medicine 2001; 20: 453–472.

6. Campbell MK , Grimshaw JM . Cluster randomised trials: time for improvement. British Medical Journal 1998; 317: 1171–1172.

7. Ukoumunne OC , Gulliford MC , Chinn S , Sterne JAC , Burney PGJ . Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment 1999; 3: iii–92.

8. Smeeth L , Siu-Woon Ng E . Intraclass correlation coefficients for cluster randomized trials in primary care: data from the MRC trial of the Assessment and Management of Older People in the Community. Controlled Clinical Trials 2002; 23: 409–421.

9. Family Heart Study Group . Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. British Medical Journal 1994; 308: 313–320.

10.

10. Jolly K , Bradley F , Sharp S et al. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of Southampton heart integrated care project (SHIP). British Medical Journal 1999; 318: 706–711.

11.

11. Moher M , Yudkin P , Wright L et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. British Medical Journal 2001; 322: 1338–1342.

12.

12. Campbell M , Grimshaw J , Steen N . Sample size calculations for cluster randomised trials. Journal of Health Services Research and Policy 2000; 5: 12––.

13.

13. Kinmonth A-L , Woodcock A , Griffin S , Spiegal N , Campbell MJ . Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. British Medical Journal 1998; 317: 1202–1208.

14.

14. Smith SM. The North Dublin Diabetes Shared Care (DiSC) Project: a randomised controlled tiral with qualitative and economic analyses. MD Thesis, University College Dublin, 2002.

15.

15. O'Donner A , Wells G . A comparison of confidence interval methods for the intraclass correlation coefficient. Biometrics 1986; 42: 401––.

16.

16. Spiegelhalter DJ , Abrams KR , Myles JP . Bayesian approaches to clinical trials and health-care evaluation. Chichester: Wiley 2004.

17.

17. Spiegelhalter DJ , Best NG . Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Statistics in Medicine 2003; 22: 3687––.

18.

18. Spiegelhalter DJ , Thomas A , Best NG . WinBUGS Version 1.2 User Manual. Cambridge: MRC Biostatistics Unit 1999.

19.

19. Brooks SP . Markov chain Monte Carlo method and its application. The Statistician 1998; 47: 69––.

20.

20. Spiegelhalter DJ , Best NG , Carlin BP , van der Linde A . Bayesian measures of model complexity and fit (with discussion). Journal of the Royal Statistical Society, Series B 2002; 64: 583––.

21.

21. Feder G , Griffiths C , Eldridge S , Spence M . Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial. British Medical Journal 1999; 318: 1522––.

22.

22. Ukoumunne OC . A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials. Statistics in Medicine 2002; 21: 3757––.

23.

23. Searle SR . Linear models. New York: Wiley 1971.

24.

24. Greenhouse JB , Wasserman L . Robust Bayesian methods for monitoring clinical trials. Statistics in Medicine 1995; 14: 1379––.

25.

25. Prevost TC , Abrams KR , Jones DR . Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening. Statistics in Medicine 2000; 19: 3359––.

26.

26. Ibrahim JG , Chen MH . Power prior distributions for regression models. Statistical Science 2000; 15: 46––.

27.

27. Tan SB , Dear KB , Bruzzi P , Machin D . Strategy for randomised clinical trials in rare cancers. British Medical Journal 2003; 327: 47––.

28.

28. Eddy DM , Hasselblad V , Schachter R . Meta-analysis by the confidence profile method: the statistical synthesis of evidence. San Diego, CA: Academic Press 1992.

29.

29. Chaloner K . Elicitation of prior distributions. In Berry DA , Stangl DK eds. Bayesian biostatistics. New York: Marcel Dekker 1996; 141–156.

30.

30. Tritchler D . Modelling study quality in meta-analysis. Statistics in Medicine 1999; 18: 2135––.

31.

31. Premaratne UN , Sterne JAC , Marks GB , Webb JR , Azima H , Burney PGJ . Clustered randomised trial of an intervention to improve the management of asthma: Greenwich asthma study. British Medical Journal 1999; 318: 1251––.

32.

32. Fahey TP , Peters TJ . What constitutes controlled hypertension? Patient based comparison of hypertension guidelines. British Medical Journal 1996; 313: 93––.

33.

33. Eccles M , Grimshaw J , Steen N et al. The design and analysis of a randomized controlled trial to evaluate computerized decision support in primary care: the COGENT study. Family Practice 2000; 17: 180––.